Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.12.2 (
MEK
)
18,161
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Tumor cells overexpress amino acid transporters to meet the increased demand for amino acids. PQ loop repeat-containing (PQLC)2 is a cationic amino acid transporter that might be involved in cancer progression. Here, we show that upregulation of
PQLC2
is critical to gastric cancer (GC) development in vitro and in vivo. Both
PQLC2
mRNA and protein were overexpressed in GC tissues, especially of the diffuse type. Overexpression of
PQLC2
promoted cell growth, anchorage independence, and tumor formation in nude mice. This was due to activation of
MEK
/ERK1/2 and PI3K/AKT signaling. Conversely,
PQLC2
knockdown caused growth arrest and cell death of cancer cells and suppressed tumor growth in a mouse xenograft model. These results suggest that targeting
PQLC2
is an effective strategy for GC treatment.
...
PMID:Cationic amino acid transporter PQLC2 is a potential therapeutic target in gastric cancer. 3072 15